Is the FDA Too Cautious?
Open to Debate
The Importance of Data in Drug Approval
Colin Peterson: I feel like we're on the precipice of a major revolution in biomedicence. If only the agency can kind of get on board with more than they have already, he says. "I think from some of the questions that were put forth about breaking down silos or using existing pathways more broadly,"Peterson adds. The final round is when each debater gets two minutes to make their closing argument.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
